Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 445 News Items found Science Byte A Clean Break: Scientists Make Surprising Discoveries about DNA Repair Friday, January 6, 2017 A study reveals unexpected insights into how cells prepare broken DNA strands to be rejoined, preventing mutations that can cause cancer. A Message From MSK’s President and CEO, Dr. Selwyn Vickers Saturday, July 1, 2023 In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life. Quantum Leap Friday, April 1, 2022 MSK investigators are leading the way with approaches so bold they are like the difference between "a snapshot and a movie." Feature Understanding the DNA-Damage “First Responders”: John Petrini at Work Thursday, March 2, 2017 Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack. In the Lab Communal Behavior within Cells Makes Cancers Easier to Target Thursday, November 10, 2016 Findings about proteins called molecular chaperones are shedding new light on possible approaches to cancer treatment. Your Impact: The Society, Fred’s Team, and Virtual Health Education Seminars Friday, October 1, 2021 Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world. From Breaks to Breakthroughs Saturday, January 1, 2022 Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work. In the Lab A Study of Rare Tumors Uncovers the Presence of Tumor-Suppressing Genes Thursday, August 30, 2018 Studying the genes of granular cell tumors has revealed a previously unknown process through which cells can turn cancerous. Harnessing the Power of Data for Patient Care Wednesday, April 1, 2020 Computational biology is helping to bring predictive power and precision to oncology. MSK Research Highlights, May 18, 2023 Thursday, May 18, 2023 New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer